🚨
We're eyeing AXP for a strategic multi-entry swing trade based on strong technical structure and long-term potential. Here's the plan:
📌 Entry Points:
1️⃣ $248 – First touch on short-term support
2️⃣ $234 – Healthy correction zone
3️⃣ $219 – Strong base of demand
🔻 Deeper Load Zone: $195 – Long-term trendline + major accumulation area
💰 Profit Targets:
✅ $285 – Previous resistance / key breakout level
✅ $300 – Psychological barrier & momentum zone
✅ $310+ – Blue sky potential 🚀
This laddered entry strategy gives us great risk management while maximizing upside. AXP remains a solid name with strong fundamentals, making it a low-volatility winner in volatile markets.
📊 Ideal for patient traders and swing setups.
⚠️ Disclaimer: This is not financial advice. All investments involve risk. Please do your own research or consult a financial advisor before making any trading decisions.
We're eyeing AXP for a strategic multi-entry swing trade based on strong technical structure and long-term potential. Here's the plan:
📌 Entry Points:
1️⃣ $248 – First touch on short-term support
2️⃣ $234 – Healthy correction zone
3️⃣ $219 – Strong base of demand
🔻 Deeper Load Zone: $195 – Long-term trendline + major accumulation area
💰 Profit Targets:
✅ $285 – Previous resistance / key breakout level
✅ $300 – Psychological barrier & momentum zone
✅ $310+ – Blue sky potential 🚀
This laddered entry strategy gives us great risk management while maximizing upside. AXP remains a solid name with strong fundamentals, making it a low-volatility winner in volatile markets.
📊 Ideal for patient traders and swing setups.
⚠️ Disclaimer: This is not financial advice. All investments involve risk. Please do your own research or consult a financial advisor before making any trading decisions.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.